Cerus Corporation (CERS) Investor Relations Documents

Cerus Corporation (CERS) investor relations documents from the company's IR site: 1 presentation, 37 press releases; latest deck 2026-04-21. Read in-app with summaries. First-party data.

https://s26.q4cdn.com/467285195/files/doc_downloads/2026/04/April-2026-Website-Deck.pdf — Cerus Corporation (April 2026) provides 2026 product revenue guidance of $224M–$228M, targeting positive non-GAAP adjusted EBITDA and P&L leverage.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-30Press releaseCerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
2026-06-17Press releaseCerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th Internation
2026-06-08Press releaseCerus Corporation Closes New Debt Facility of Up to $110 Million
2026-04-30Press releaseCerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
2026-04-27Press releaseCerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
2026-04-21Presentationhttps://s26.q4cdn.com/467285195/files/doc_downloads/2026/04/April-2026-Website-Deck.pdf
2026-03-16Press releaseCerus Appoints Vivek Jayaraman as President and Chief Executive Officer
2026-03-03Press releaseCerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference
2026-03-02Press releaseCerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026
2025-11-06Press releaseDownload
2025-11-06Press releaseCerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025
2025-08-05Press releaseCerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025
2024-10-30Press releaseCerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
2024-10-16Press releaseCerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
2024-08-01Press releaseCerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024
2024-05-02Press releaseCerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
2023-11-02Press releaseCerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023
2023-08-02Press releaseCerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023
2023-05-04Press releaseCerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023
2023-02-28Press releaseCerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
2022-11-03Press releaseCerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
2022-08-04Press releaseCerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022
2022-06-14Press releaseCerus Corporation Celebrates World Blood Donor Day 2022
2022-04-22Proxy statement2022 Notice of Annual Meeting and Proxy Statement of 2021 Annual Report, PDF file, (opens in new window)
2022-04-21Press releaseCerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
2022-02-25Press releaseCerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference
2022-02-08Press releaseCerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
2022-02-07Press releaseCerus Corporation to Participate in Upcoming Virtual Investor Conferences
2021-11-08Press releaseCerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
2021-10-19Press releaseCerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021
2021-09-15Press releaseCerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference
2021-08-04Press releaseCerus Corporation Announces Appointment of Ann Lucena to Board of Directors
2021-07-20Press releaseCerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021
2021-07-14Press releaseCerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets
2021-04-23Proxy statement2021 Notice of Annual Meeting and Proxy Statement of 2020 Annual Report, PDF file, (opens in new window)
2021-04-20Press releaseCerus Corporation to Release First Quarter 2021 Financial Results on May 4, 2021
2021-03-11Press releaseCerus Corporation to Participate in Jefferies Virtual Global Plasma Summit
2021-02-11Press releaseCerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
2020-12-15Press releaseCerus’ Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Cen
2020-12-04Press releaseCerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the Ame

CERS overview · CERS earnings · CERS financials · CERS KPIs · CERS ownership · CERS peers · CERS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.